Lead the development and execution of reimbursement and health economic strategies for Structural Heart (SH) products in EMEA.
Develop clinical and economic evidence, health economic evaluations, and customer-facing economic tools.
Facilitate understanding and prioritization of market access needs across EMEA countries.
Direct execution of health economic projects including cost-effectiveness analyses to support market access strategies.
Analyze and communicate clinical & economic evidence to target audiences including publication of research findings.
Represent Reimbursement and Health Economics at external meetings.
Requirements
Postgraduate degree (MS, MPH, MPP, MBA, PhD or MD) in Economics, Health Economics, Life Sciences, Health Policy or related field required
7+ years market access experience for medical devices or pharmaceutical products (reimbursement, health economics, HTA and funding applications)
7+ years’ experience in health economics, outcomes research or medical device technology assessment, with a track record of successful reimbursement and funding applications in the health care environment.
Good knowledge of the application, development and review of health economic models
Experience in conducting outcomes research projects and developing value propositions
Good knowledge of reimbursement systems in Europe
Fluent in English
Excellent oral and written communication skills, ability to work across cultures, strong project management skills, results orientation, quality orientation.